New drug combo shows promise for rare thymic cancer
NCT ID NCT04710628
First seen Feb 19, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study tested a combination of two drugs, pembrolizumab and lenvatinib, in 43 people with advanced thymic carcinoma or a related thymoma that had worsened after standard chemotherapy. The goal was to see if the combination could stop or slow cancer growth. Participants received the drugs as pills or infusions, and researchers tracked how long they lived without their cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC THYMIC CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
A.O.U. San Luigi Gonzaga
Orbassano, Italy
-
Centre Hospitalier Universitaire de Toulouse
Toulouse, France
-
Centre Oscar Lambert
Lille, France
-
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, Spain
-
Hospital Clinic i Provincial de Barcelona
Barcelona, 08036, Spain
-
Hospital Sant Creu i Sant Pau
Barcelona, Spain
-
Hospital Universitari i Politècnic La Fe
Valencia, Spain
-
Hospital Universitario La Paz
Madrid, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hôpitaux Universitaires de Marseille - Hôpital Nord
Marseille, France
-
IGR Gustave Roussy
Villejuif, France
-
Institut Bergonié
Bordeaux, France
-
Institut Curie
Paris, France
Conditions
Explore the condition pages connected to this study.